by the FDA in August. Zurzuvae works more quickly to treat depression symptoms than traditional antidepressants. But the high price tag has some experts concerned that everyone who needs the treatment won't be able to get it.have postpartum depression symptoms, the CDC says. Postpartum depression may cause people to think about hurting their babies or themselves.
“The gold standard of mental health care is a combination of psychotherapy and medication when medication is needed,” said Catherine Monk, PhD, chief of the Division of Women’s Mental Health in the Department of Obstetrics and Gynecology at the Columbia University Vagelos College of Physicians and Surgeons.
Zurzuvae, which is also known by its generic name of zuranolone, is the first oral treatment for postpartum depression. It is taken for 14 days and was shown in trial results to significantly reduce depression symptoms for at least 4 weeks. People who take zuranolone should not drive for 12 hours after taking it due to the potential for drowsiness and impairment. Before the oral option, patients had to get zuranolone through an IV at a health care facility.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WGAL - 🏆 331. / 59 Read more »